We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New MRI Technique Could Mean Fewer Breast Biopsies in High-Risk Women

By HospiMedica International staff writers
Posted on 20 Jul 2009
A biomedical engineer and colleagues have developed a technique that, utilized with magnetic resonance imaging (MRI) scans of the breast, could spare some women with increased breast cancer risk the pain and stress of having to endure a biopsy of a questionable lump or lesion. More...
The universal technology will give radiologists greater confidence in visually categorizing a lesion as malignant or benign.

The American Cancer Society (Atlanta, GA, USA) recommends that women with certain breast cancer risk factors including inherited genetic mutations, family, or personal history of breast cancer, or previous radiation therapy to the chest receive a yearly screening in addition to their yearly mammogram.

During a breast MRI, which lasts about 30 minutes, the technician injects a contrast agent into a vein in the patient's arm. Over time, the contrast agent flows throughout the body, including the breasts. Because they are growing quickly, cancerous lesions frequently have immature vasculature, and the contrast agent flows in and "leaks” out rapidly. On the other hand, benign lesions show more gradual in and out flow.

"The tricky ones are the ones that enhance quickly and then fall off more slowly,” said Dr. Wally Block, a University of Wisconsin-Madison (UW-Madison; USA) associate professor of biomedical engineering and medical physics. "Many of these lesions turn out to be difficult to classify and lead to biopsy.”

However, it turns out that with the right sort of MRI scan, radiologists can visually identify a cancerous lesion based on characteristics about its shape. For example, breaks or interruptions in a lesion can indicate a benign fibroadenoma. Lumps with smooth edges often are benign, while those with jagged edges can signal cancer.

To generate the kind of precise, three-dimensional (3D) images necessary for such a diagnosis, Dr. Block, UW-Madison radiology associate professor Dr. Fred Kelcz, and graduate student Catherine Moran are capitalizing on their unique MRI data-acquisition method.

An MR image is made up of thousands of smaller pieces of data. The traditional data-acquisition method gathers that information slowly, and it is designed to be viewed from a single imaging plane. "What people do now is they compromise,” said Dr. Block. "They don't get resolution in the other planes to make it a reasonable scan time. We found a way around that.”

With the team's powerful technique, an MRI machine acquires data radially and generates a high-resolution, 3D image that radiologists can turn, slice, and view from many perspectives enabling them to evaluate a lesion's physical characteristics more carefully. Machines equipped with the technique also acquire more data in less time.

Moreover, the method also makes it possible for radiologists to view fat images and water images separately, which is particularly useful because fat composes a large portion of the breast. "Rarely is disease associated with fat,” noted Dr. Block. "Most of the time radiologists are concentrating on water images, but sometimes our fat images of the breast are also useful. The boundaries of a lesion often stand out very clearly when embedded in fat.”

The investigators currently are collecting data on the efficacy of the technique. They have tested the method on 20 patients at the University of Wisconsin Hospital and have shared it with colleagues at the University of Toronto (Canada) for additional assessment. They also are working with Michigan State University researchers to test the technique.

Collaborating with Dr. Scott Reeder, a UW-Madison assistant professor of biomedical engineering and radiology, Dr. Block and colleagues also are fine-tuning ways to image both breasts simultaneously a development that could decrease scan time and free valuable MRI space for additional patients. "If you have a screening procedure that you want people to participate in regularly, you want to make it convenient for them,” concluded Dr. Block.

Related Links:

University of Wisconsin-Madison




Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Spirometry & Oximetry Software
MIR Spiro
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.